Received: 2 April 2019
Accepted: 11 April 2019
First Online: 4 June 2019
Ethics approval and consent to participate
: The study protocols were reviewed and approved by the appropriate institutional review board for each of the study sites. The studies were conducted according to Good Clinical Practice and the Declaration of Helsinki guidelines. Patients provided written informed consent before undergoing study procedures.
: Not applicable.
: Daniel D. Mikol is a full-time employee of Amgen Inc. Thousand Oaks, California. Josefin Snellman is a full-time employee of Novartis Pharma A.G. Basel, Switzerland.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.